1597PTRASTUZUMAB/AT-101 COMBINATION INDUCES APOPTOSIS AND SHOWS SYNERGISTIC CYTOTOXICITY IN HER2-POSITIVE BREAST CANCER CELLS BY INHIBITION OF PI3K SIGNALING: A NOVEL COMBINATION TO OVERCOME RESISTANCE TO ANTI-HER2 THERAPY